Multiplex microsphere‐based flow cytometric platforms for protein analysis and their application in clinical proteomics – from assays to results
- 3 December 2009
- journal article
- review article
- Published by Wiley in Electrophoresis
- Vol. 30 (23), 4008-4019
- https://doi.org/10.1002/elps.200900211
Abstract
Advances in high‐throughput screening, together with rapid progress in genomic and proteomic sciences, have considerably stimulated the development of a variety of biomarker discovery tools and have contributed to the improvement of clinical diagnosis. Major challenges include the obtaining of high‐quality data sets based on assays that are rapid, reliable, and inexpensive, but still highly sensitive and easy to perform. The microsphere‐based flow cytometric technology is a platform that is currently entering the diagnostic market. This article reviews the development and the applications of microsphere‐based flow cytometric platforms in basic and applied proteomic research, and discusses bead‐based assays used in clinical applications.This publication has 85 references indexed in Scilit:
- The multiplex bead array approach to identifying serum biomarkers associated with breast cancerBreast Cancer Research, 2009
- Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics ProgramsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal CohortClinical Cancer Research, 2008
- Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancerBreast Cancer Research, 2008
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisCritical Care, 2007
- Multiplexed and microparticle‐based analyses: Quantitative tools for the large‐scale analysis of biological systemsCytometry Part A, 2006
- Standardizing the standardsMolecular Systems Biology, 2006
- Application of genome-wide expression analysis to human health and diseaseProceedings of the National Academy of Sciences, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001